311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster I

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicente

High Risk of Thrombosis in a Prospective Cohort of Adults with Primary Immune Thrombocytopenia

Evaluation of the Efficacy and Safety during Treatment with TPO-Ras in 40 SLE-ITP and APS-ITP Patients

Immunotherapy-Associated Immune Thrombocytopenia: Treatment Paradigms

Impact of Age on Hemostasis of Patients with Immune Thrombocytopenia

The Lack of Tolerable Treatment Options That Can Induce Durable Responses without Fear of Relapse after Discontinuation Represents a Significant Unmet

The Combination of Intravenous Immunoglobulin (IVIG) and Low Does Recombinant Human Thrombopoietin (rhTPO) for the Management of Corticosteroid/IVIG M

Proposal of New Diagnostic Criteria for Primary Immune Thrombocytopenia

Quality of Life in Childhood Immune Thrombocytopenia: Revision of the Kids’ ITP Tools (KIT)

Effect of Hetrombopag Combined with Rhtpo in Patients with Severe Immune Thrombocytopenia

Eltrombopag Plus Rhtpo for Corticosteroid-Resistant or Relapsed ITP: A Prospective Observed Study

RUNX1 Haplodeficiency Reduces Platelet Endocytosis of Albumin and Fibrinogen and Impairs Megakaryocyte Intracellular Trafficking

The Role of Gpiba in Control of Megakaryocyte Reactivity to Thrombopoietin

Thrombocytopenia – Is It an Impactful Prognostic Indicator in Patients with Liver Cirrhosis?

Genetic Study of Patients with Severe Dense Granule Deficiency: Unraveling the Underlying Genetic Complexity of Hermansky-Pudlak Syndrome

Platelet Electron Microscopy Does Not Correlate with Bleeding Scores in a Pediatric Population

Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospecti

Interim Baseline Characteristics of Adult Patients with Immune Thrombocytopenia Enrolled in the Observational Multicenter Phase 4 Adopt Study to Evalu